Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationHematologic NeoplasmsMelphalanGraft vs Host DiseaseStem Cell TransplantationCombined Modality TherapyGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Myeloablative AgonistsBlood Component RemovalMultiple MyelomaCyclophosphamideBusulfanTreatment OutcomeBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsGraft SurvivalHematopoietic Stem CellsLymphoma, Non-HodgkinRemission InductionRecurrenceEtoposideThiotepaAntineoplastic Agents, AlkylatingTransplantation ChimeraTissue DonorsCord Blood Stem Cell TransplantationWhole-Body IrradiationCarmustineSalvage TherapyCytophagocytosisDisease-Free SurvivalRetrospective StudiesHematopoiesisIfosfamideHistocompatibilityHistocompatibility TestingVincristineSurvival RateHodgkin DiseaseAmyloidosisStem CellsCytarabineSurvival AnalysisVidarabineTime FactorsImmunosuppressive AgentsNeoplasmsLeukemia, Myeloid, AcuteInfectionLeukemiaLiver TransplantationUnrelated DonorsGraft vs Leukemia EffectLymphoma, T-CellFollow-Up StudiesDoxorubicinTransplantation, IsogeneicPlatelet CountPOEMS SyndromeMyelodysplastic SyndromesPrednisoneCytomegalovirus InfectionsCarboplatinHLA AntigensAntineoplastic AgentsLymphomaDexamethasoneProspective StudiesBlood Cell CountRecombinant ProteinsGraft vs Tumor EffectBlood CellsHematologic DiseasesAnemia, AplasticBone Marrow PurgingKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell TransplantationSiblingsFatal OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineLymphocyte DepletionFeasibility StudiesT-LymphocytesImmunosuppressionTransplantation ImmunologyPrognosisImmunophenotypingMesenchymal Stem Cell TransplantationChimerismDonor SelectionBone Marrow